Drug Shortage Report for PRALUENT
| Report ID | 176325 |
| Drug Identification Number | 02453835 |
| Brand name | PRALUENT |
| Common or Proper name | PRALUENT 150 mg |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ALIROCUMAB |
| Strength(s) | 150MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 2 |
| ATC code | C10AX |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2022-12-02 |
| Actual start date | |
| Estimated end date | 2022-12-23 |
| Actual end date | 2022-12-22 |
| Shortage status | Resolved |
| Updated date | 2022-12-23 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2022-12-23 | English | Compare |
| v8 | 2022-12-22 | French | Compare |
| v7 | 2022-12-22 | English | Compare |
| v6 | 2022-12-03 | English | Compare |
| v5 | 2022-11-29 | French | Compare |
| v4 | 2022-11-29 | English | Compare |
| v3 | 2022-11-29 | French | Compare |
| v2 | 2022-11-29 | English | Compare |
| v1 | 2022-11-29 | English | Compare |
Showing 1 to 9 of 9